Compare Digital Realty Trust, Inc. (DLR) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Digital Realty Trust, Inc. vs Heron Therapeutics Inc — how do they compare? Digital Realty Trust, Inc. trades at $178.48 (market cap $65.32B), while Heron Therapeutics Inc trades at $0.4 (market cap $68.01M). The key difference: Digital Realty Trust, Inc. is far larger — about 960.4× Heron Therapeutics Inc's market cap, and Digital Realty Trust, Inc. pays a 2.77% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Digital Realty Trust, Inc. for 93 Days and Heron Therapeutics Inc for 35 Days on average.
| DLR | HRTX | |
|---|---|---|
Market Cap | $65.32B | $68.01M |
Volume | 2,563,950 | 1,891,941 |
Sector | Real Estate | Health |
52-Week High | $203.91 | $1.49 |
52-Week Low | $147.93 | $0.27 |
Typical Hold Time | 93 Days | 35 Days |
Enterprise Value | $84.03B | $174.75M |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Digital Realty Trust (DLR) trades at $178.15, down 1.29% with a bearish technical outlook. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $1.21 versus $0.48 expected, and revenue growth from $6.11B in 2025 to projected $6.8B in 2026. Analyst consensus is strongly bullish with 34 buys and a $222.35 price target, supported by AI-driven data center demand and recent infrastructure expansions.
DLR presents a compelling growth opportunity driven by AI infrastructure demand, with record interconnection activity and strategic partnerships. Key risks include high valuation multiples (P/E 85.89) and significant capital expenditures. The technical bearish signal contrasts with strong fundamental momentum, creating potential for volatility near-term.
HRTX trades at $0.3967, up 1.72% today, with a bullish technical signal from moving averages but mixed earnings. The company reported a net loss of $20.20 million in 2025, with revenue of $154.90 million, and has a high gross margin of 70.07% but negative profitability metrics. Recent Q2 2026 results missed EPS estimates, though Q4 2025 beat expectations. Analyst consensus is strongly bullish with 17 buy ratings.
The outlook is cautious due to persistent losses and cash burn, but strong analyst support and a low P/S ratio of 0.44 may appeal to value investors. Key risks include ongoing unprofitability and competitive pressures in the biotech sector. Investors should weigh the high institutional optimism against fundamental challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Digital Realty Trust, Inc.
Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.
Read more on DLR →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
